Skip to content

Executive functions and COVID

Assessment of executive functions in long COVID

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-5qmxt6m
Enrollment
Unknown
Registered
2023-08-22
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Acute COVID-19 Syndrome

Interventions

This is an analytical, cross-sectional study, with a convenience sample calculated on 64 participants using G*Power 3.1.9.7 software. Covid Group: 32 individuals who had a positive RT-PCR test or rapi

Sponsors

Universidade do Oeste Paulista
Lead Sponsor
Felipe Viegas Rodrigues
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Medicine undergraduate students; adults

Exclusion criteria

Exclusion criteria: psychiatric disorders prior to the COVID-19 episode; with known neurological pathologies; dyschromatopsia; have intoxication by narcotic or psychostimulant; no RT-PCR and/or rapid test for diagnostic confirmation.

Design outcomes

Primary

MeasureTime frame
Assess the presence of executive dysfunction through neuropsychological tests of attention, working memory and cognitive flexibility, which indicate a decrease in reaction times or an increase in the percentage of errors in patients with post-COVID-19 syndrome.

Secondary

MeasureTime frame
To assess the prevalence of psychiatric symptoms, using the Depression Anxiety and Stress Scale (DASS-21) - Short Form, in people who had COVID-19. Compare the impairments of Post-Acute COVID-19 Syndrome in men and women.

Countries

Brazil

Contacts

Public ContactFelipe Rodrigues

Universidade do Oeste Paulista

felipe@unoeste.br+55(18)996838488

Outcome results

None listed

Source: REBEC (via WHO ICTRP)